Dr. Andreas Persidis is the co-founder and CEO of Biovista Inc. and since 2010 is the President of the Hellenic BioCluster (HBio). He is a member of the European Innovation council, a member of the H2020 Expert Advisory Group on Innovation for SMEs, an expert reviewer and evaluator for the European Commission and the Austrian government, has managed on behalf of the European Commission a roadmap study on systematic innovation, and has advised the Hellenic government on innovation strategy and research priorities in the areas of IT and the life sciences.
Prior to Biovista, Dr. Persidis managed technology development teams at European corporations in the engineering, software and telecoms fields. Dr. Persidis has conducted research in the fields of machine learning and applied Artificial Intelligence, which has led to the launch of international research projects. He has published extensively in international journals, co-authored book chapters in systematic drug repositioning and is an invited speaker at forums on drug repositioning, innovation and export oriented high-tech companies. He speaks English, Greek and French.